feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Amber Alert issued Washington

trending

Peter Greene found dead NYC

trending

Wembanyama returns for NBA Cup

trending

Mortgage rates declining slightly

trending

Geminid meteor shower peaks tonight

trending

Powerball jackpot reaches $1 billion

trending

Cincinnati storm brings school closings

trending

Robby Hoffman Netflix comedy special

trending

Selena Quintanilla's father passed away

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / King Charles Continues Cancer Treatment, Shares Hopeful Update

King Charles Continues Cancer Treatment, Shares Hopeful Update

13 Dec

•

Summary

  • King Charles will scale back his cancer treatment starting in 2026.
  • His cancer was detected during treatment for an enlarged prostate.
  • The King expressed gratitude for the 'community of care' surrounding patients.
King Charles Continues Cancer Treatment, Shares Hopeful Update

In a rare video statement, King Charles III announced that his cancer treatment will be scaled back beginning in 2026. He described this milestone as a personal blessing and a testament to advances in cancer care, emphasizing the life-saving impact of early diagnosis. The King shared that his own condition has allowed him to continue his duties while undergoing treatment.

While Buckingham Palace has not disclosed whether the cancer is in remission, a spokesperson stated that the King has responded "exceptionally well" to treatment. The ongoing measures will now transition to a "precautionary phase" to ensure his continued recovery, subject to ongoing monitoring. The public learned of his cancer diagnosis in February 2024, with the form of the illness remaining private.

Following his diagnosis and the commencement of treatment, King Charles resumed his public-facing duties in late March 2024, starting with an Easter Sunday service. He has since continued his royal responsibilities. The King conveyed his empathy for those facing a cancer diagnosis, stating he was moved by the "community of care" available to patients.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
King Charles III plans to scale back his cancer treatment starting in 2026.
King Charles III's cancer was detected while he was undergoing treatment for an enlarged prostate.
Buckingham Palace has not confirmed if King Charles III is in remission but stated he has responded well to treatment.

Read more news on

Healthside-arrowKing Charles IIIside-arrow

You may also like

King Shares Health Milestone: Cancer Treatment Reduced

19 hours ago • 2 reads

article image

King Charles Battles Cancer, Shares Personal Message

1 day ago • 5 reads

article image

King Charles III Shares Health Update

1 day ago • 9 reads

article image

Queen's 1949 Card Reveals Lilibet Nickname Origin

9 Dec • 24 reads

article image

Prince William eyes change for royal Christmas gifts

8 Dec • 30 reads

article image